PACE Trial Management Group

The The PACE Trial Management Group is credited as an author of the PACE trial. It was responsible for the day-to-day running and management of the trial.

Chair

 * Peter D. White, MD, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London, UK

Principal investigators

 * Peter D. White, MD, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London, UK (Also served as the PACE Trial Management Group Chair)


 * Trudie Chalder, PhD, Academic Department of Psychological Medicine, King's College London, London, UK (Also was a centre leader)


 * Michael Sharpe, MD, Psychological Medicine Research, School of Molecular and Clinical Medicine, University of Edinburgh, Edinburgh, UK

Centre leaders

 * Brian J. Angus, MD, Nuffield Department of Medicine, University of Oxford, The John Radcliffe Hospital, Oxford, UK


 * Trudie Chalder, PhD, Academic Department of Psychological Medicine, King's College London, London, UK (Also served as a principal investigator)


 * Eleanor Feldman, MRCPsyc, University of Oxford, Dept of Psychological Medicine, Barnes Unit, John Radcliffe Hospital, Headington, Oxford, UK


 * Gabrielle Murphy, MSc, Royal Free Hospital NHS Trust, London, UK


 * Maurice Murphy, FRCP, Barts and the London NHS Trust, London, UK


 * H. O’Dowd, PhD, Frenchay Hospital NHS Trust, Bristol, UK


 * Tim Peto, RCP, Nuffield Department of Medicine, John Radcliffe Hospital, Headington, Oxford, UK


 * Michael Sharpe, MD, Psychological Medicine Research, School of Molecular and Clinical Medicine, University of Edinburgh, Edinburgh, UK (Also served as a principal investigator)


 * Peter D. White, MD, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London, UK (Also served as Chair and a principal investigator)


 * D. Wilks, FRCP[Ed], Western General Hospital, Edinburgh, UK


 * Simon Wessely

Treatment leaders

 * Jessica Bavinton, BSc, Barts and the London NHS Trust, London, UK


 * Mary Burgess, PhD, South London and Maudsley NHS Foundation Trust, London, UK


 * Diane L. Cox, PhD, Faculty of Health and Well Being, University of Cumbria, Lancaster, UK


 * Gabrielle Murphy, MSc, Royal Free Hospital NHS Trust, London, UK (Also served as a centre leader)

Health economists

 * Martin Knapp


 * Paul McCrone, PhD, Centre for the Economics of Mental Health Service and Population, King's College London, London, UK

Trial statisticians

 * Rebecca Walwyn, MSc, Mental Health and Neuroscience Clinical Trials Unit, Institute of Psychiatry, King's College London, London, UK


 * Anthony L. Johnson, PhD, Medical Research Council Biostatistics Unit, Institute of Public Health, University of Cambridge, UK and Medical Research Council Clinical Trials Unit, London, UK

Trial Manager

 * Julia C. DeCesare, MSc, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London, UK

Observers

 * Chris Clark, (for Action for ME)


 * Alison Wearden (observer for FINE trial)

Data Manager/Senior Research Secretary

 * Sandy Smith

Other members

 * Kimberley A. Goldsmith, MSc, MPH, Mental Health and Neuroscience Clinical Trials Unit, Institute of Psychiatry, King's College London, London, UK


 * Hannah L. Baber, MSc, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London, UK


 * L.V. Clark, PhD, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London, UK


 * Laura Potts, MSc, Mental Health and Neuroscience Clinical Trials Unit, Institute of Psychiatry, King's College London, London, UK


 * Sir Peter Spencer

PACE Trial Management Group manuscripts

 * 2013, "Recovery from chronic fatigue syndrome after treatments given in the PACE trial"
 * 2011, "Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial"
 * 2007, "Protocol for the PACE trial: A randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with the chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy"
 * 2006PACE Final Protocol Version 5.0